What happened
GeneOne Life Science updated a previously disclosed supply contract with TuHURA Biosciences, Inc., now worth US$402K, about 1.43% of its recent annual revenue, running through Feb 2026.
For context, this single contract equals about 1.43% of the company's most recent annual revenue.
| Counterparty | TuHURA Biosciences, Inc. |
|---|---|
| Contract value | US$402K |
| vs. recent revenue | 1.43% |
| Through | Feb 2026 (from Oct 2024) |
| Filed | 2026-02-27, [Amended] Supply contract signed |
| Source | DART rcept 20260227801042 → open original filing |
Source: DART. Information only, not investment advice.